🔎 Trials Near Me

Home › Skin Conditions › Indiana

Skin Conditions clinical trials in Indiana

7 studies for Skin Conditions are looking for participants at sites in Indiana.

Cities in Indiana

A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema

  • Dawes Fretzin Clinical Research Group, LLC, Indianapolis
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Nov 6, 2026 · NCT07783425

Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp

  • The Indiana Clinical Trials Center, PC, Plainfield
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Nov 4, 2026 · NCT07144345

A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata

  • Dawes Fretzin Clinical Research Group, LLC, Indianapolis
  • The South Bend Clinic Center for Research, South Bend
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Nov 4, 2026 · NCT05723198

Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities

  • The Indiana Clinical Trials Center, PC, Plainfield
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Nov 4, 2026 · NCT07144852

A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (The SKYLIGHT Trial)

  • Site 101, Indianapolis
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 19, 2026 · NCT07766005

Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa

  • Options Research Group, Llc, West Lafayette
RecruitingPhase 1
Ages 12 to 75 · All sexes · Updated Oct 9, 2026 · NCT07049575

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

  • DS Research of Southern Indiana,LLC, Clarksville
  • Dawes Fretzin Clinical Research Group, LLC, Indianapolis
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Aug 28, 2026 · NCT07599813

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.